Biomerica (BMRA) Income from Non-Controlling Interests (2017)
Biomerica (BMRA) reported Income from Non-Controlling Interests of $680893.0 for Q2 2017.
Biomerica (BMRA) Income from Non-Controlling Interests (2017) Analysis & Trends
Biomerica (BMRA) has 1 years of Income from Non-Controlling Interests data on file, last reported at $680893.0 in Q2 2017.
- For the quarter ending Q2 2017, Income from Non-Controlling Interests changed N/A year-over-year to $680893.0; the trailing twelve-month figure through May 2017 stood at $680893.0 (changed N/A YoY), and the FY2021 full-year result was $936615.0, changed N/A from the prior year.
- Income from Non-Controlling Interests was little changed at $680893.0 in Q2 2017.
- In the past five years, Income from Non-Controlling Interests ranged from a high of $680893.0 in Q2 2017 to a low of $680893.0 in Q2 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.01 Bn | 175.72 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.76 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 108.90 Bn | 99.68 Bn | 6.41 Bn | 16.00 Mn |
| 4 | Boston Scientific | 68.43 Bn | 66.98 Bn | 3.61 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 47.96 Bn | 44.29 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 28.29 Bn | 26.01 Bn | 1.98 Bn | 22.00 Mn |
| 7 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | - |
| 9 | Koninklijke Philips | 25.44 Bn | 22.31 Bn | 2.07 Bn | -5.85 Mn |
| 10 | Biomerica | 4.88 Mn | 3.54 Mn | -44,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2017 | 680,893.00 |